Catalyst Wire Dossier Catalyst Wire Dossier

KELNOR 1/35

ETHYNODIOL DIACETATE AND ETHINYL ESTRADIOL · Teva Pharmaceuticals USA, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for KELNOR 1/35, covering 2017-08-09 to 2022-04-29. Get the full timeline:

Most recent: FDA Approved: KELNOR 1/35 — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

See pricing